InspireMD
NSPR
16 hedge funds and large institutions have $169K invested in InspireMD in 2022 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 3 closing their positions.
0.2% less ownership
Funds ownership: 1.56% → 1.36% (-0.2%)
6% less funds holding
Funds holding: 17 → 16 (-1)
33% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 3
35% less capital invested
Capital invested by funds: $259K → $169K (-$90.6K)
50% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$28.7K |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$3.13K |
| 3 |
Bank of America
Charlotte,
North Carolina
|
+$305 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
-$36.5K |
| 2 |
Millennium Management
New York
|
-$28K |
| 3 |
Simplex Trading
Chicago,
Illinois
|
-$5 |
NSPR Hedge Fund Activity: Q3 2022 in Review
16 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in InspireMD (NSPR) for Q3 2022, worth a combined $169K — down 35% from $259K a quarter earlier.
Sellers outnumbered buyers: 3 funds closed out of NSPR and 2 opened new positions — a net loss of 1 holder — while 2 trimmed existing stakes and 1 added.
The largest buyer was Susquehanna International Group, opening a new position worth an estimated $28.7K. The largest seller was Bridgeway Capital Management, cutting an estimated $36.5K.
- 16 institutional investors held InspireMD (NSPR) as of Q3 2022, down from 17 in Q2 2022.
- Funds reported $169K of InspireMD stock for Q3 2022, down 35% quarter-over-quarter.
- 2 funds opened new InspireMD positions in Q3 2022 and 3 closed out, a net change of -1 holder.
- The largest InspireMD buyer in Q3 2022 was Susquehanna International Group, an estimated $28.7K added.
- The largest InspireMD seller in Q3 2022 was Bridgeway Capital Management, an estimated $36.5K sold.
Based on aggregated 13F filings for Q3 2022.